Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa's World-Wide Webinar Series, "Impact of Modeling & Simulation in Drug Development"
By: Rebecca Baillie, Rosa & Co | February 06, 2012
Dr. Derendorf, will present "PK/PD-based Development of Anti-infective Agents" February 13, 2012.
 Read This Pharmaceutical Article |
Eisenberg & Associates to Handle Unintended Pregnancy Claims Resulting from the Pfizer Birth Control Pill Recall
By: Larry Eisenberg, Lawrence S. Eisenberg & Assoc. | February 03, 2012
Pfizer has announced a recall of one million packages of birth control pills due to defective packaging. The recall is of Lo/Ovral 28 and Norgestrel/Ethinyl Estradiol birth control pills manufactured by Pfizer and sold by Akrimax Pharmaceuticals.
Read This Pharmaceutical Article |
Detroit Law Firm Will Handle Lo/Ovral-28 Claims
By: Brian McKeen, McKeen & Associates | February 03, 2012
Attorney Brian J. McKeen announced that his Detroit law firm, McKeen & Associates, PC, will begin handling claims related to the Pfizer birth control pill recall.
Read This Pharmaceutical Article |
The Bright Path Ishayas Enables Crystal Meth Addict to Find Help and Free Addiction
By: Amanda Campbell, The Brigth Path Ishayas | February 03, 2012
The Bright Path Ishayas and their teachings had a profound impact on one crystal meth addicted individual, who struggled with the addiction for nearly six years, experiencing the horrors and side effects of the drug.
Read This Pharmaceutical Article |
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
By: Carolyn Rhinebarger, Luminovas | February 03, 2012
Niiki Pharma announced today the formation of its Scientific Advisory Board. Daniel Haller M.D. will chair the advisory board, and will be joined by Lee Ellis M.D. and Matt Kulke M.D. The Board will provide clinical and strategic guidance.
Read This Pharmaceutical Article |
BioScience Laboratories Announces Testing Capabilities for Murine Norovirus
By: Kyle McGovern, BioScience Laboratories | February 02, 2012
BioScience Laboratories announces the capability of product efficacy testing versus Murine Norovirus. Murine (Mouse) Norovirus (MNV) is a surrogate for Human Norovirus.
Read This Pharmaceutical Article |
Multi-Benefit Blemish Balm Facial Cream Makes American Debut Out of Ariel Labs
By: Ilena DellaVentura, Delia Assoiates | February 02, 2012
Ariel Laboratories, the custom product development laboratory headquartered in South Plainfield, NJ, has formulated a facial cream with multi-purpose properties, including UVB protection.
Read This Pharmaceutical Article |
Molecular Obesity, Potency and other Addictions in Medicinal Chemistry
By: EIN News | February 02, 2012
Drug Design Conference will aim to address many of the challenging issues faced by the pharmaceutical industry in drug design.
Read This Pharmaceutical Article |
Rosa to present at 2012 Keystone Symposia: Cancer and Metabolism
By: Rebecca Baillie, Rosa & Co | February 02, 2012
Modeling analysis enables understanding efficacy of large numbers of potential drug combinations.
Read This Pharmaceutical Article |
Chandra Chatterjee, Ph.D., Named a VIP Member of Cambridge Who's Who for Excellence in Medical Imaging and Marketing
By: Ellen Campbell, Cambridge Who's Who | February 01, 2012
Chandra Chatterjee, Ph.D., has established world-class training tools for health care product usage
Read This Pharmaceutical Article |
Specialty Hospital Of America Launches Dynamic New Online Presence
By: Mark Ballard, Social Kaboom | January 31, 2012
Company adds newly designed wesbites and social media networks to better serve patients and residents.
Read This Pharmaceutical Article |
Benefits of a Facelift
By: Sara Goldstein, ePR Source | January 30, 2012
Since the introduction of BOTOX Cosmetic, nonsurgical facial rejuvenation treatments have exploded.
Read This Pharmaceutical Article |
The Specialty Hospital of Washington Introduces Breakthrough Technology for Patients with Fluid Overload
By: Mark Ballard, Social Kaboom | January 30, 2012
New Aquapheresis treatment can replace expensive diuretic medications.
Read This Pharmaceutical Article |
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
By: Rebecca Baillie, Rosa & Co | January 30, 2012
Industry presenters will focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development
Read This Pharmaceutical Article |
Illinois Case May Have Major Impact on Medical Error Reporting
By: FL Web Advantage | January 28, 2012
An upcoming Illinois Supreme Court case may open the door to making information about medical mistakes available to the public.
Read This Pharmaceutical Article |
European Recalls of Diabetes Drug a Sign of Things to Come?
By: FL Web Advantage | January 28, 2012
The results of a preliminary study by the Food and Drug Administration (FDA) in June found that those taking the drug Actos were at a higher risk of developing the serious disease.
Read This Pharmaceutical Article |
Subject of Brutal Fan Beating, Bryan Stow, on the Path to Recovery
By: FL Web Advantage | January 28, 2012
On March 31, 2011, opening day of baseball season, Giants fan Bryan Stow was brutally beaten outside of Dodger Stadium in Los Angeles. This merciless beating left Stow, a paramedic and avid fan of the visiting San Francisco Giants, with a severe traumatic brain injury.
Read This Pharmaceutical Article |
enaltus has Emerged as a New, Privately-Held Georgia-Based Company Following the Acquisition of its Prior Parent Company, Advanced Bio-Technologies, Inc. by Sinclair IS Pharma in December 2011
By: Lee Jacobson, enaltus | January 27, 2012
The new entity offers specialty skin care products to physicians and consumers in the US and internationally with distributors and partners in over 50 countries around the world.
Read This Pharmaceutical Article |
Chicago Marijuana Bust Emphasizes Importance of Landlord Consent Issue
By: FL Web Advantage | January 27, 2012
Chicago Police drug discovery raises issues of when landlords can consent to searches of leased property.
Read This Pharmaceutical Article |
FDA Wants Contraceptive Labels to Be More Detailed
By: FL Web Advantage | January 27, 2012
As questions linger about the risks of some widely used contraceptives such as Yaz and Yasmin, a Food and Drug Administration (FDA) advisory committee recently recommended adding more information about potential risks to their safety labels.
Read This Pharmaceutical Article |
|
Advertise With Us |
About Us |
Contact Us